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Abstract 
 
The creation of dynamic materials that undergo morphological transitions with 
respect to environmental factors may aid in the targeting and treatment of various 
diseases.  A hallmark of cancer is the presence of low extracellular pH within tumors.  
Therefore, the creation of novel diagnostic agents that undergo morphological transitions 
at precise pH values in the bloodstream can allow for the enhanced accumulation of 
imaging agents in tumor tissue due to differences in diffusion properties of different 
assembled states.  Peptide amphiphiles (PAs) are an intriguing class of biocompatible 
vehicles that are comprised of a lipid tail, a short sequence of amino acids, and may be 
functionalized with various therapeutic or diagnostic moieties.  PAs have been observed 
to undergo a micelle-to-nanofiber (basic-to-acidic) transition at a broad range of pH 
values in simulated serum environments.  This transition is known to be tunable via 
alterations in the identity of the amino acid residues, the number of charged residues, the 
ionic strength of the solution, and the length of the fatty acid tail.  However, until now no 
study has investigated the effects of rearranging the position of amino acid residues on 
self-assembly behavior.  Here, using palmitoyl-IAAAEEEE-NH2 and palmitoyl-
IAAAEEEEK(DO3A:Gd)-NH2 as well-characterized control PA systems, I studied how 
sequence variation controls the self-assembly behavior, specifically in the novel systems 
of palmitoyl-AIAAEEEE-NH2 and palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2.  
Interestingly, moving the hydrophobic isoleucine one amino acid away from the 
palmitoyl tail increases the pH of transition between spherical micelles and nanofibers by 
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greater than 2 pH units.  By increasing the distance between the isoleucine and the alkyl 
tail, the tendency of the side chain to collapse hydrophobically with the alkyl tail is 
reduced, allowing increased participation in hydrogen bonding beta-sheets and stabilizing 
the nanofiber.  These findings reveal a novel strategy for programming pH-triggered self-
assembly by isomerizing the peptide sequence. 
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Chapter 1 
 
Introduction 
 
 Cancer is a leading cause of death worldwide. According to the World Health 
Organization, cancer caused 7.6 million deaths in 2008 (approximately 13% of 
worldwide deaths)1. An increase in early detection rates for all cancer types is paramount 
for increasing survival rates. For example, the 5-year survival rate for breast cancer 
diagnosed at a localized stage is 98.6%, while the 5-year survival rate once the cancer has 
metastasized is only 23.3%2. For these reasons, the demand for imaging agents capable of 
selectively targeting tumor tissue at earlier stages is rising. 
Since the late 1990s, the growing field of molecular biology and the increasing 
ease with which genomes can be sequenced have promoted the usage of personalized 
medicine, or the customization of treatment based on a patient’s genetic information.  
With regards to cancer, the sequencing of the genome of cancerous cells in comparison to 
healthy cells has led to treatment options involving matching specific active tumor-
targeting drugs to patients whose tumors match the specified genome3.  Although this 
approach often leads to initial improvements in a patient’s condition, these gains are 
many times followed by the aggressive reappearance of tumor growth and eventual death 
of the patient4.  This mysterious and devastating phenomenon was recently elucidated by 
a study finding genetic deviations not only between cancerous cells and healthy cells, but 
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also among cells within a single tumor5.  Tumor heterogeneity is the downfall of 
personalized medicine because, while the targeted cancerous cells may be killed off, any 
cancer cells present without the targeted surface markers return (and in greater numbers).  
The research outlined in this thesis is part of a larger plan to pursue a strategy for tumor 
imaging which relies on the characteristics that are alike in all forms of cancer.  This 
model may be useful for targeted drug delivery applications in the future. 
 Recent research has indicated that size and shape of intravenously injected 
nanomaterials significantly affect biodistribution6,7,8,9.  This phenomenon has been in part 
explained by the enhanced permeability and retention (EPR) effect in which 
nanoparticles of low zeta-potential, high solubility, and of between 20 and 200 nm 
diameter tend to evade immune system recognition and organ clearance leading to longer 
circulation lifetimes10.  With regards to shape, cylindrical polymeric fibers have been 
shown to have a 10 times longer circulation time in the bloodstream than their spherical 
counterparts11.    When targeting cancer, the high interstitial fluid pressure of tumor tissue 
results in diffusion becoming the most important mass transport process.  Therefore, 
vehicles of small diameter permeate tumor tissue most easily.  Therapeutic attempts at 
exploiting this effect have been ineffective due to small vehicles both entering and 
leaving tumor tissue at enhanced rates, leading to decreased accumulation12.  Therefore, a 
vehicle that begins with a small diameter to permeate the tumor tissue and transforms into 
a vehicle of larger diameter to enhance retention within the tumor would be ideal.  
However, most nanomaterials previously investigated are either static objects which do 
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not transform in the cancer environment or fragment into smaller pieces to release an 
imaging or medicinal load upon reaching their target13.   
 Designing nanomaterials that spontaneously change shape and size in response to 
physiological stimuli allows for the exploitation of the aforementioned different diffusion 
kinetics of nanosized carriers, enhancing their accumulation at a given target.  Although 
cancer refers to not one, but many diseases, most forms of cancers possess at least two 
exploitable characteristics.  The first of these is a slightly acidic microenvironment (pH 
6.6-7.4)14 resulting from the enhanced rate of glycolysis in the rapidly growing cancer 
cells.  The second, also resulting from uncontrolled growth and relating most directly to 
diffusion kinetics, is the leaky and irregular lymphatic vasculature resulting in an 
enhanced permeability and retention of nano-sized particles.  
To take advantage of these two features, this thesis makes use of a class of 
molecules known as peptide amphiphiles (PAs)15.  PAs are an attractive class of 
molecules for the purpose of targeting cancer cells for several reason: they can 
spontaneously self-assemble into nanofibers, their intermolecular forces may be tuned 
precisely via modification to their peptide sequence, and they are biocompatible.  A goal 
of this thesis is to create and test a peptide amphiphile (PA) that undergoes a spherical 
micelle to nanofiber transition in environments similar in ionic strength and pH 
conditions to that of tumor tissue (Figure 1.1).  
The Goldberger group has previously developed a general PA design scheme that 
allows for fine-tuning the transition from spherical micelles to polymeric cylindrical 
micelles by tenths of pH units.  This design involves four main segments: a hydrophobic 
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alkyl tail, followed by a β sheet-forming peptide region, a charged amino acid sequence, 
and a C-terminal macrocyclic Gd3+ chelate for MRI-imaging applications (Figure 1.2).  
Increasing and decreasing pH is known to increase and decrease the degree of ionization 
of the charged sequence.  This change in ionization has been found to provide a sufficient 
trigger for dynamic self-assembly.  Exploration of this design strategy has culminated in 
the synthesis and characterization of a PA, palmitoyl-IAAAEEEEK(DO3A:Gd)-NH2 
(Figure 1.2), which has been observed to undergo a sphere-to-nanofiber transition at 
acidic pHs in simulated serum salt solution (150 mM NaCl and 2.2 mM CaCl2) with a 
low concentration dependence (Figure 1.5).  The supramolecular structure of the PA in 
salt solution was monitored via circular dichroism (CD) spectroscopy, critical 
aggregation concentration (CAC) measurements, and verified at higher concentrations 
using transmission electron microscopy (TEM).  This transition was determined to be 
rapid and reversible, occurring in less than three minutes.  Despite this success, the 
transition of palmitoyl-IAAAEEEEK(DO3A:Gd)-NH2 from spherical micelle to 
nanofiber was found to occur at  5.7-6.0 pH at or above the detectable concentration limit 
for MRI applications (10 µM)16.  This transition pH is significantly lower than the 6.6-7.4 
pH range necessary for tumor targeting applications.  The parent molecule of this MRI-
active derivative has also been synthesized and studied: palmitoyl-IAAAEEEE-NH2 
(Figure 1.3).  Under identical conditions, this PA exhibited a sphere-to-cylinder transition 
with significantly higher concentration dependence (Figure 1.4)17.  Therefore, further 
optimization is required to develop a PA capable of pH-triggered tumor targeting. 
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Previous studies involving peptides and peptide amphiphiles have explored the 
relationship between sequence variation through the rearrangement of amino acids in the 
peptide’s primary structure and self-assembly morphology18,19.  However, the effects of 
sequence isomerization have never been studied in a dynamically self-assembling system 
with an environmental trigger (such as pH).  The purpose of this study is to establish a 
relationship between the position of the β sheet-forming residue in the primary peptide 
sequence and the pH of transition.  To accomplish this, previously studied PAs were 
isomerized to create palmitoyl-AIAAEEEE-NH2 (Figure 1.6) and palmitoyl-
AIAAEEEEK(DO3A:Gd)-NH2 (Figure 1.7). 
In Chapter 2, the synthesis, purification, and characterization procedures for both 
molecules are outlined.  Additionally, proof of product identity and purity is contained in 
Chapter 2.  Chapter 3 describes the construction of pH- and concentration-dependent 
phase diagrams for both new PAs.  This process includes data collected via CD, CAC 
measurements, and images taken using conventional TEM.  Chapter 4 extensively 
compares the phase diagrams of the newly synthesized isomers with their previously 
characterized parent molecules.  Chapter 5 provides a summary of this thesis as well as 
future work planned in this area. 
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Figure 1.1: Illustration of previously observed peptide amphiphile self-assembly behavior 
 
Figure 1.2: Schematic representation of a peptide amphiphile contrast agent, showing the 
4 regions contributing to the molecules unique, self-assembling properties are shown; the 
hydrophobic region (Blue), β sheet-forming region (Orange), the charged region (Red), 
and the MRI-Active region (green). Note: PA shown here is palmitoyl-
IAAAEEEEK(DO3A:Gd). 
 
 
Figure 1.3: Structure of palmitoyl-IAAAEEEE-NH2 
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Figure 1.4: Concentration and pH dependent phase diagram for palmitoyl-
IAAAEEEEK(DO3A:Gd)-NH2 in  150 mM NaCl, 2.2 mM CaCl217 
 
Figure 1.5: Concentration and pH dependent phase diagram for palmitoyl-
IAAAEEEEK(DO3A:Gd)-NH2 in  150 mM NaCl, 2.2 mM CaCl217. 
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Figure 1.6: Structure of palmitoyl-AIAAEEEE-NH2 
 
Figure 1.7: Structure of palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 
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Chapter 2 
 
Materials and Methods 
 
Synthesis of Peptides Amphiphiles 
 
For this study, two peptide amphiphiles were created: palmitoyl-AIAAEEEE-NH2 
and palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2. Both peptide amphiphiles were 
synthesized using amino acids purchased from AnaSpec Inc. unless otherwise noted.  
PAs were built upon a Sieber resin using standard FMOC chemistry20 from the C-
terminus to N-terminus.  PAs were synthesized manually on a 0.50 mmol scale using the 
following procedure: 
The Sieber resin was placed in a shaker vessel and swelled with dichloromethane 
(DCM) for 30 minutes, then again swelled with dimethyl formamide (DMF) for 30 
minutes.  The solvent was removed and a solution of 20% N,N-Diisopropylethylamine 
(DIPEA) in DMF was added to the vessel.  The mixture was shaken for 10 minutes.  The 
solution was drained, replenished, and shaken for another 10 minutes.  The DIPEA/DMF 
solution was drained again and the resin was rinsed several times with DMF, then with 
DCM.  A Kaiser test was used to confirm the removal of the FMOC protecting group.  To 
couple amino acids to the deprotected resin or peptide chain, activation of the amino acid 
using O-Benzotriazole N,N,N’,N’-tetramethyluroniumhexafluorophosphate (HBTU) or, 
for higher coupling efficiency, 2-(7-Aza-1H-benzotriazole-1-ly)-1,1,3,3-
tetramethyluronium hexafluorophosphate (HATU) was employed.  Each coupling 
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solution contained 3.95 equivalents of the amino acid desired, 4 equivalents of N-
hydroxybenzotriazole (HOBt) or 1-Hydroxy-7-azabenotriazole (HOAt), 4 equivalents of 
HBTU or HATU, and 6 equivalents of DIPEA with respect to peptide.  A few drops of 
Triton X-100 (surfactant) were also added to prevent aggregation and increase coupling 
efficiency.  The coupling solution was dissolved in DMF, mixed, and added to the shaker 
vessel.  Each coupling reaction was allowed at least 2 hours to shake before the next 
deprotection.   
 
Cleavage from Resin 
 
Following completion of the peptide, palmitoyl-AIA2E4-NH2 was cleaved using a 
highly acidic trifluoroacetic acid (TFA) cocktail containing 95% TFA, 2% Millipore 
water, 2% anisole, and 1% triisopropylsilane.  This cocktail ensured removal of peptide 
from the resin as well as deprotection of the tert-butyl ester groups from the glutamic 
acid residues.  The cocktail was added to the resin and shaken for 3 hours, followed by a 
30 minute rinse with DCM.  Following cleavage, palmitoyl-AIA2E4-NH2 was rotovapped 
to remove DCM and TFA.  The peptide was then crashed out of solution using cold 
diethyl ether.  The precipitate was filtered and purified (see section below). 
Following termination of palmitoyl-AIA2E4K-NH2 with a palmitic acid tail, a 
mildly acidic cleavage cocktail was prepared. The cleavage cocktail contained 96% 
DCM, 2% anisole, 1% triisopropylsilane, and 1% TFA.  This cocktail ensured removal of 
the peptide from resin and the removal of the lysine residue’s Mtt protecting group while 
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maintaining the tert-butyl ester protection of the glutamic acid residues.100 mL of the 
cleavage cocktail was prepared.  The cocktail was added to the resin in 20 mL increments 
and allowed to shake for 20 minutes after addition, then drained into a round bottom 
flask.  Following exhaustion of the cleavage cocktail, a final rinse of DCM was added to 
the resin and allowed to shake for 30 minutes, then drained into the flask.  A portion of 
DIPEA equimolar to the total amount of TFA used was added to the flask and excess 
solvent was removed under vacuum.  The peptide was crashed out of solution using cold 
water, then filtered. 
 
Addition of DOTA to palmitoyl-AIAAEEEEK-NH2 
 
Following the precipitation palmitoyl-AIAAEEEEK-NH2, a 1,4,7,10-
tetraazacyclododecane-1,4,7-trisacetic acid (DO3A) chelate was added using solution 
phase coupling.  The PA was added to pyridine and stirred until dissolved at 60 oC.  The 
solution was then allowed to stir at room temperature. A coupling solution containing a 
small amount of pyridine, 2 equivalent HATU, 4.4 equivalents of DIPEA, and 2 
equivalents of DO3A (relative the peptide) was prepared.  This solution was added to the 
PA and the combination was stirred overnight.  Excess pyridine was then removed under 
vacuum and the peptide was crashed out using cold water, then filtered.  The resulting 
solid was then stirred in a deprotection cocktail containing 95% TFA, 2% Millipore 
water, 2% anisole, and 1% triisopropylsilane. The deprotection cocktail was stirred at 
room temperature for 24 hours.  Excess TFA was removed under vacuum and the peptide 
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was precipitated out of solution using cold diethyl ether followed by filtration.  The 
resulting solid was purified as described below. 
 
Purification of PAs 
 
The crude PA was dissolved in a 10% acetonitrile aqueous solution with a few 
drops of NH4OH added to aid in solubility.  Following dissolution, the PA solution was 
filtered using a 0.45 µm polytetrafluoroethylene (PTFE) filter.  Purification was 
performed using a Shimadzu preparative high performance liquid chromatography 
(HPLC) system (dual pump system controlled by LC-MS solution software) with an 
Agilent PLRP-S polymer column (Model No. PL1212.3100 150 mm x 25 mm) under 
basic conditions.  The product was eluted using a linear gradient from 10% acetonitrile to 
20% acetonitrile over 22.5 minutes, followed by a linear gradient from 20% acetonitrile 
to 40% acetonitrile over an additional 67.5 minutes, both containing 0.1% NH4OH (v/v).  
The presence of the desired product in collected fraction was confirmed using 
electrospray ionization time-of-flight mass spectrometer (ESI-TOF MS) (Bruker).  The 
purity of product-containing samples was assayed usinga Shimadzu analytical HPLC 
system.  Samples of high purity were combined.  Pure fractions were relieved of 
acetonitrile under vacuum and freeze-dried to produce a white, fluffy powder.  For MS 
confirmation of successful PA synthesis see Figure 2.1 and Figure 2.2 for palmitoyl-
AIAAEEEE-NH2 and palmitoyl-AIAAEEEEK(DO3A:Gd), respectively.  For analytic 
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HPLC confirmation of PA purity, see Figure 2.3 and Figure 2.4 for palmitoyl-
AIAAEEEE-NH2 and palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 respectively.   
 
Chelation of PA with Gd3+ 
 
A small amount (~15 mg) of the purified and fully deprotected palmitoyl-
AIAAEEEEK(DO3A) was dissolved in water with 2 equivalents of GdCl3 in 0.01 M 
HCl.  The solution was raised to exactly 5.0 pH using small amounts of 0.05 M NaOH 
and stirred at 60 oC for 10 minutes. The reaction was brought back to room temperature 
and the pH was again adjusted to pH 5.0 since the reaction results in a lowering of pH.  
The reaction was returned to 60 oC and stirred overnight.  The solution was then returned 
to room temperature and the pH was adjusted to 10 or greater using 0.1 M NaOH to 
precipitate excess Gd3+ in the form of Gd(OH)3.  The solution was then filtered using a 
0.45 µm PTFE filter and the pH was adjusted to neutral using 0.1 M HCl.  The solution 
was then dialyzed against Millipore water.  The buffer water was changed 4 times over a 
48 hours period.  The dialyzed solution was then freeze-dried to create a fluffy white 
powder: pure palmitoyl-AIAAEEEEK(DO3A:Gd). 
 
Circular Dichroism 
 
Measurements were completed using a CD spectrometer (Jasco-815).  Each 
spectra is the average of 3 accumulations, baseline subtracted using an aqueous solution 
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containing only 150 mM NaCl and 2.2 mM CaCl2.  PA solutions were prepared at basic 
pH containing 1.00 mM PA and no salts.  Samples containing various concentrations of 
the aqueous PAs with 150 mM NaCl and 2.2 mM CaCl2 were prepared and heated at 80 
oC for 30 minutes at 9 or greater pH.  After heating, samples were allowed to cool to 
room temperature and pH was adjusted as desired for CD measurements. 
 
Determination of Critical Aggregation Concentration (CAC) 
 
 The pyrene 1:3 method17 was used to determine CAC.  For both palmitoyl-
AIAAEEEEK(DO3A:Gd)-NH2 and palmitoyl-AIAAEEEE-NH2 CAC measurements 
were performed at pH of 5, 6, 7, 8, and 10.  Samples of high peptide concentration (300-
750 µM) were prepared containing 150 mM NaCl and 2.2 mM CaCl2.  These samples 
were raised to 9 or greater pH using dilute NaOH and heated at 80 oC for 30 minutes.  
Samples were allowed to cool to room temperature and pH was altered to the desired 
value using dilute NaOH and HCl.  Solutions containing only aqueous 150 mM NaCl and 
2.2 mM CaCl2 and solutions containing these salts, a 1:1 solution of water and methanol, 
and 62 µM pyrene were also prepared.  Each of these solutions was divided into five 
portions and adjusted to an appropriate pH (5, 6, 7, 8, 10).  The PA solutions were 
serially diluted with the corresponding salt solutions with a total of 125 µL at each 
concentration.  5 µL of the pyrene containing solution as added to each dilution for a final 
pyrene concentration of 2.4 µM.  Each dilution was probed for fluorescence with an 
excitation wavelength of 335 nm.  Fluorescence was recorded with particular attention 
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paid to the 376 nm and 392 nm emission peaks.  The ratio of these two peaks was plotted 
versus PA concentration on a log scale. 
 
Transmission Electron Microscopy 
 
TEM images were obtained at various concentrations and pH values, with 150 
mM NaCl and 2.2 mM CaCl2 in deionized water. Solutions were heated at 80 oC for 30 
minutes in an oil bath and gradually cooled to room temperature.  Following temperature 
equilibration, pH adjustment was achieved using HCl or NaOH. 5 µL of this solution was 
pipetted onto a Carbon Formvar grid (Electron Microscopy Sciences) and allowed to sit 
for 2 minutes before being wicked dry. The samples were negatively stained with 1 wt% 
uranyl acetate and imaged under a FEI Tecnai G2 Bio TWIN TEM system operating at 
100 kV.  
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Figure 2.1: ESI-TOF mass spectrum of palmitoyl-AIAAEEEE-NH2 
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Figure 2.2: ESI-TOF mass spectrum of palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 
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Figure 2.3: Analytic HPLC chromatogram of palmitoyl-AIAAEEEE-NH2 
 
Figure 2.4: Analytic HPLC chromatogram of palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 
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Chapter 3 
 
Construction of Phase Diagrams 
 
Following synthesis and purification, efforts were made toward creating two-
dimensional (pH- and concentration-dependent) phase diagrams for both of palmitoyl-
AIAAEEEEK(DO3A:Gd)-NH2 and palmitoyl-AIAAEEEE-NH2.  All measurements for 
all methods, unless otherwise indicated, were performed in simulated serum salt 
conditions (150 mM NaCl and 2.2 mM CaCl2).   
 
Circular Dichroism  
 
CD spectra were compiled for both palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 and 
palmitoyl-AIAAEEEE-NH2 to determine the prominent secondary structure of the 
peptide at concentrations of 5 µM and greater.  Previously, a β sheet CD signal has been 
correlated to a nanofiber morphology and a random coil CD signal has been correlated to 
a spherical micelle or single molecule morphology17. When using CD, β sheet is signaled 
by an ellipticity minimum at 218 nm and random coil, by an ellipticity maximum at 212 
nm and a minimum at 196 nm18.  For the purpose of this simple system, the transition 
from spherical micelle (random coil) to nanofiber (β sheet) was determined to take place 
just as the ellipticity at 205 nm first became positive.  This transition was observed to be 
concentration dependent as well, with higher concentrations favoring a β sheet secondary 
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structure even at high pH values.  This concentration dependence was greater for 
palmitoyl-AIAAEEEE-NH2 than for palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2. 
CD data for palmitoyl-AIAAEEEE-NH2 at 5 µM revealed a transition from 
random coil to β sheet between pH values of 7.05 and 7.12.  These data are shown in 
their entirety in Figure 3.1.  For all subsequent CD spectra, no greater than four pH-
dependent traces shall be shown for the sake of clarity.  Within these four shall be 
included the two pH-dependent traces on either side of the random coil-to-β sheet 
transition.  At 10 µM this transition increased to pH values between 6.16 and 6.26 
(Figure 3.2).  At 12.5 µM the transition shifted higher still, to between pH 8.13 and 8.26 
(Figure 3.3). By concentrations of 15 and 30 µM, no transition could be found and the PA 
exhibited a β sheet signal independent of pH (Figure 3.4 and Figure 3.5).  
CD analysis of palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 at 5 µM revealed a 
transition between β sheet and random coil between  pH values of 6.44 and 6.55 (Figure 
3.6).  At 10 µM this transition point increased to between pH 7.09 and 7.15 (Figure 3.7).  
By 25 µM, the transition was observed between pH 7.67 and 7.80 (Figure 3.8).  Between 
50 µM and 150 µM, the transition seemed relatively constant, observed between pH 7.92 
and 8.04 and between 7.94 and 8.05, respectively (Figure 3.9 and Figure 3.10). 
The reversibility of this transition was also tested using CD.  A sample of 5 µM 
palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 initially was brought to pH 8.55 and a CD 
spectrum was acquired. This solution was then acidified to pH 5.65 and another spectrum 
was recorded.  The solution pH was again raised back to 8.55 and spectra were recorded 
every 15 minutes for 45 minutes (Figure 3.11). Although the spectra reflected a random 
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coil signal, none of the spectra taken within the 45 minutes after returning to pH 8.55 
were superimposable with the original pH 8.55 spectrum. 
 
Critical Aggregation Concentration  
 
The CAC for palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 and palmitoyl-
AIAAEEEE-NH2 were determined at 5 pH values by the method described in Chapter 2.  
CACs for palmitoyl-AIAAEEEE-NH2 were determined to be 2.0 µM, 2.6 µM, 2.5 µM, 
3.2 µM, and 13.4 µM for pH 5, 6, 7, 8, and 10 respectively (Figures 3.12-3.15).  A clear 
relationship between pH and CAC is evident in these data and is illustrated in Figure 
3.12, which shows the CAC determination for pHs 5 and 10 superimposed in a single 
chart.  This relationship was expected.  As the PA molecule exists in a highly ionized 
state (at basic pH) aggregation is inhibited by ionic repulsion.  When the glutamic acid 
residues are more protonated (at acidic pH values) this ionic repulsion is lessened or 
eliminated, allowing aggregation at lower concentrations. 
In determining the CAC for palmitoyl-AIAAEEEEK(DO3A:Gd), a similar pH 
dependence was noted.  The dependency is illustrated in Figure 3.16, which shows the 
CAC determination for pH values of 5 and 10 superimposed in a single chart.  The CAC 
values for palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 were determined to be 1.5 µM, 3.2 
µM, 3.5 µM, 3.7 µM and 5.4 µM for pHs 5, 6, 7, 8, and 10 respectively (Figures 3.16-
3.19). 
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Transmission Electron Microscopy and Complete Phase Diagrams 
 
Following the collection of CD and CAC data, observed transitions were plotted with 
respect to pH and PA concentration to form phase diagrams for palmitoyl-AIAAEEEE-
NH2 (Figure 3.20) and palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 (Figure 3.21).  TEM 
images confirmed the presence of nanofibers in 100 µM and 10 µM palmitoyl-
AIAAEEEE-NH2 at pH 8.3 and pH 5.5, respectively (Figure 3.22).  At 10 µM under 
acidic conditions these nanofibers were relatively small, generally ranging from 100-200 
nm in length.  At 100 µM under basic conditions, these nanofibers were significantly 
longer, often exceeding 1 micron in length.  TEM also confirmed the presence of long 
nanofibers (greater than 1 micron) in 150 µM palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 
at 6.6 pH and the lack thereof at 9.9 pH (Figure 3.23).  In each case that nanofibers were 
found, the diameter of an individual nanofiber was around 10 nm. Nanofibers were 
generally found in bundles with other nanofibers. 
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 Figure 3.1: Detailed pH-dependent CD spectra of 5 µM palmitoyl-AIAAEEEE-NH2 
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 Figure 3.2: pH-dependent CD spectra of 10 µM palmitoyl-AIAAEEEE-NH2 
 
 
Figure 3.3: pH-dependent CD spectra of 12.5 µM palmitoyl-AIAAEEEE-NH2 
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Figure 3.4: pH-dependent CD spectra of 15 µM palmitoyl-AIAAEEEE-NH2 
 
Figure 3.5: pH-dependent CD spectra of 30 µM palmitoyl-AIAAEEEE-NH2 
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 Figure 3.6: pH-dependent CD spectra of 5 µM palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 
 
 
 Figure 3.7: pH-dependent CD spectra of 10 µM palmitoyl-AIAAEEEEK(DO3A:Gd)-
NH2 
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 Figure 3.8: pH-dependent CD spectra of 25 µM palmitoyl-AIAAEEEEK(DO3A:Gd)-
NH2 
 
Figure 3.9: pH-dependent CD spectra of 50 µM palmitoyl-AIAAEEEEK(DO3A:Gd)-
NH2
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Figure 3.10: pH-dependent CD spectra of 150 µM palmitoyl-AIAAEEEEK(DO3A:Gd)-
NH2  
 
 
 Figure 3.11:  Reversibility of transition, 5 µM palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 
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Figure 3.12: palmitoyl-AIAAEEEE-NH2 pH-dependent CAC determination (pH 5 &10)  
 
 
Figure 3.13: palmitoyl-AIAAEEEE-NH2 CAC determination at pH 6  
(CAC 2.6 µM)  
(CAC 2.0 µM)  
(CAC 13.4 µM)  
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Figure 3.14: palmitoyl-AIAAEEEE-NH2 CAC determination at pH 7  
 
 
Figure 3.15: palmitoyl-AIAAEEEE-NH2 CAC determination at pH 8  
(CAC 3.15 µM)  
(CAC 2.5 µM)  
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Figure 3.16: palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 pH-dependent CAC determination 
(pH 5 &10)   
 
 
Figure 3.17: palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 CAC determination at pH 6  
(CAC 3.2 µM)  
(CAC 1.5 µM)  (CAC 5.4 µM)  
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Figure 3.18: palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 CAC determination at pH 7  
 
 
 
Figure 3.19: palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 CAC determination at pH 8  
(CAC 3.5 µM)  
(CAC 3.7 µM)  
33 
 
 
Figure 3.20: palmitoyl-AIAAEEEE-NH2 phase diagram 
 
 
Figure 3.21: palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2  phase diagram    
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Figure 3.22: TEM images of 10 µM palmitoyl-AIAAEEEE-NH2 at 5.5 pH (left) and 100 
µM at 8.3 pH (right)  
 
 
Figure 3.23: TEM images of 150 µM palmitoyl-AIAAEEEEK(DO3A Gd) at pH 6.6 (left) 
and 9.9 (right)  
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Chapter 4 
 
Comparison of Isomerized Peptide Amphiphiles 
 
 By overlaying the phase diagrams of isomeric PAs lacking the DO3A imaging 
moiety (Figure 4.1) and the phase diagrams of isomeric PAs with the DO3A imaging 
moiety (Figure 4.2), the effects of sequence variation within the β sheet-forming region 
were analyzed.  The creation of sequence variants in both cases resulted in lower CAC 
concentrations at nearly all pH values.  Therefore, moving the Ile residue to the second 
position promotes single molecule aggregation. 
 By examining CD data in each phase diagram, it is evident that by moving Ile to 
the second beta sheet forming position, aggregation from spherical micelle to nanofiber is 
promoted at higher pH.  This is most evident in the DO3A-containing molecules (Figure 
4.2) due to their lower concentration dependence.  For instance, at 10 µM palmitoyl-
AIAAEEEEK(DO3A:Gd)-NH2 transitions from sphere-to-nanofiber at pH 7.1.  This 
transition pH is nearly 1.5 units higher than that for palmitoyl-IAAAEEEEK(DO3A:Gd)-
NH2 at the same concentration.  Notably, palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 
shows a much higher concentration dependence for its transition than palmitoyl-
IAAAEEEEK(DO3A:Gd)-NH2.  Between 10 and 500 µM, the pH for transition of 
palmitoyl-IAAAEEEEK(DO3A:Gd)-NH2 lies in the range from 5.66 to 6.02 (less than 
0.5 pH).  Contrastingly, the transition for palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 
between 5 and 150 µM spans a range from  6.5 to 8.0 (pH 1.5).  This concentration 
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dependence seems to decrease at high concentrations for palmitoyl-
AIAAEEEEK(DO3A:Gd)-NH2, since between 50 and 150 µM the transition remains 
constant at pH 8.0  
 Comparison of the CD data for non-DO3A-containing isomers is more difficult 
due to the high concentration dependence the sphere-to-nanofiber transition exhibits for 
both isomers.  In general, palmitoyl-AIAAEEEE-NH2 seems to favor the nanofiber 
morphology at higher pH values compared to palmitoyl-IAAAEEEE-NH2.  At 10 µM, 
palmitoyl-IAAAEEEE-NH2 displays a sphere-to-nanofiber transition at pH 6.5, while its 
isomer shows a transition at pH 7.35 (a shift of nearly 0.9 pH unit). Additionally, 
palmitoyl-IAAAEEEE-NH2 exhibits a solely nanofiber morphology above 20 µM 
concentration while its isomer is exclusively nanofibers at all concentrations above 15 
µM. 
 
 
37 
 
 
Figure 4.1: Superimposed phase diagrams of palmitoyl-AIAAEEEE-NH2 (blue) and 
palmitoyl-IAAAEEEE-NH2 (pink) 
 
 
Figure 4.2: Superimposed phase diagrams of palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 
(blue) and palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 (pink)  
38 
 
Chapter 5 
 
Conclusions and Future Directions 
 
 In exploring the effects of β sheet isomerization on pH-triggered PA self-
assembly, creating a space of one amino acid between the β sheet-forming residue and 
the hydrophobic core enhances aggregation of single molecules into nanofibers or 
spheres (CAC) and of spherical micelles into longer nanofibers (CD).  These trends held 
true regardless of whether a -K(DO3A:Gd)-NH2 head group was included in the PA 
structure.  For PAs lacking the MRI-active head group, shifting Ile to the second position 
causes the CAC to decrease by half or more.  For PAs containing the MRI-active head 
group, the isomerization had an even great impact, decreasing CAC by as great as seven-
fold.  The transition from sphere-to-nanofiber of palmitoyl-AIAAEEEEK(DO3A:Gd)-
NH2 was observed to be more than 2 pH units higher than palmitoyl-
IAAAEEEEK(DO3A:Gd)-NH2.  Self-assembly of palmitoyl-AIAAEEEE-NH2 into 
nanofibers was also shifted to 1 pH unit higher than palmitoyl-IAAAEEEE-NH2 at 10 
µM. These shifts resulting from isomerization are more drastic than what was previously 
observed by adding or changing the identity of the first amino acid residue17.   
Recent coarse-grained (CG) molecular dynamics (MD) simulations on a similar 
PA system, palmitoyl-VVVAAAEEE-NH2, suggest that hydrophobic residues positioned 
near the hydrophobic core of a micelle tend to associate with the hydrophobic core, 
collapsing inward (Figure 5.1).  Additionally, calculations using this CG MD model of 
palmitoyl-VVVAAAEEE-NH2 revealed that the highest degree of β-sheet character was 
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in amino acid residues 2-5 and that the percent β character in residue 1 was less than 10% 
(Figure 5.1)23.  Therefore the drastic shift in transition pH between the isomeric PA 
systems studied here is attributed to the fact that, when positioned next to the palmitoyl 
acid tail, the β sheet forming residues like Ile or Val more readily associate with the 
hydrophobic tail, destabilizing the β sheet.  As a hydrophobic residue, the positioning of 
Ile near the palmitoyl tail causes the residue to either participate in the hydrophobic 
collapse near the micelle’s core or to facilitate hydrogen bonding with neighboring PAs, 
assisting in the creation β sheet secondary structure.  Hydrophobic collapse precludes Ile 
from participating in hydrogen bonding, and vice versa.  Additionally, this collapse 
interrupts the formation of hydrogen bonds N-terminal to the interruption (Figure 5.2).  
By creating distance between Ile and the hydrophobic core (via isomerization), 
hydrophobic collapse of the Ile becomes less favorable.  Instead, the Ile hydrogen bonds 
with nearby residues of neighboring molecules (Figure 5.3). This results in the PA more 
readily assuming a nanofiber morphology.   
 Importantly, the sphere-to-nanofiber transition of palmitoyl-
AIAAEEEEK(DO3A:Gd)-NH2 between 5 and 20 µM falls well within the desired range 
for tumor targeting (pH 6.6-7.4).  For the most part, this aggregation falls at or above the 
detectable limit for MRI contrast agents.  Therefore, this PA seems to be well suited for 
future in vivo assays. 
 Our increase in understanding of the structure property relationships with the 
creation of just two pairs of isomers merit further investigation of other isomeric 
relationships.  First, the creation of more isomers from the same parent molecules (β 
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sheet sequences of –AAIA- and –AAAI-) should further confirm the role of hydrophobic 
amino acid isomerization on dynamic PA self-assembly.  Additionally, creating pairs or 
quadruplets of isomers containing a β sheet-forming amino acids other than Ile would 
verify that these results may be generalized to all PAs within this dynamic pH-trigger 
self-assembly class.  Since Ile has the highest β sheet propensity of any amino acid, an 
amino acid of particularly low a β sheet-forming propensity, such as tyrosine, would be 
interesting to study.  Specifically, study of palmitoyl-YAAAEEEEK(DO3A:Gd)-NH2 
and its isomers may yield valuable insight into the factors affecting PA self-assembly.  In 
summary, varying the amino acid sequence provides an alternate mechanism for 
drastically changing the dynamic self-assembly behavior of PAs.  This method will be 
used in the future for more intelligent programming of PA self-assembly.  
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Figure 5.1: Hydrophobic core of palmitoyl-VVVAAAEEE-NH2 comprised of alkyl tails 
(red) and valine residues (green) (left)23 and percentages of secondary structures for each 
amino acid residue in palmitoyl-VVVAAAEEE-NH2 (right)23 
 
Figure 5.2: Schematic representation of palmitoyl-IAAAEEEEK(DO3A:Gd)-NH2 
highlighting Ile association with the hydrophobic tail, thus destabilizing β-sheet 
formation. 
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Figure 5.3: Schematic representation of palmitoyl-AIAAEEEEK(DO3A:Gd)-NH2 more 
strongly participating in hydrogen-bonding. 
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